Risdiplam interactions
Full monograph for RisdiplamCheck it against another medicine
Medicines
12 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Chloroquine Phosphate | Moderate | Synergy | Theoretical concerns exist that oculotoxic effects of risdiplam, observed in monkeys, may be additive with those of other drugs that are associated with… | 15 sources — open the full entry |
| Empagliflozin + Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Fexofenadine Hydrochloride | Moderate | Excretion | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 3 sources — open the full entry |
| Glimepiride + Metformin | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Glipizide + Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Hydroxychloroquine Sulphate | Moderate | Synergy | Theoretical concerns exist that oculotoxic effects of risdiplam, observed in monkeys, may be additive with those of other drugs that are associated with… | 15 sources — open the full entry |
| Linagliptin + Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Pioglitazone + Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Sitagliptin + Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
| Trifluridine + Tipiracil | Moderate | Excretion · Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin…2 documented mechanisms | 5 sources — open the full entry |
| Vildagliptin + Metformin Hydrochloride | Moderate | Metabolism | Coadministration with risdiplam may increase the plasma concentrations and risk of adverse effects of drugs that are substrates of multidrug and toxin… | 2 sources — open the full entry |
Conditions
Conditions in which Risdiplam needs care, as documented in this source.
Liver Diseases
ModerateThe pharmacokinetics and safety of risdiplam in patients with severe hepatic impairment (Child-Pugh class C) have not been studied. In patients with mild or moderate hepatic impairment, clinically meaningful differences have not been observed.
2 sources
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Evrysdi (risdiplam)." Genentech (2020):